Pilot-scale fermentation, purification, and characterization of recombinant human Oncostatin M in Pichia pastoris

Ning Kong1, Xupeng Mu, Hongzhi Han

  • 1Department of Biological Engineering, College of Pharmacy, Jilin University, 1163 Xin Min Street, Changchun 130021, PR China.

Insights

This study optimized conditions for producing recombinant human Oncostatin M (rhOSM) in Pichia pastoris, achieving a high yield of 280 mg/L. The purified rhOSM demonstrated significant growth inhibition activity, confirming its biological efficacy.

Area of Science:

  • Biotechnology
  • Cell Biology
  • Protein Expression

Background:

  • Oncostatin M (OSM), an IL-6 subfamily member, regulates gene activation, cell survival, proliferation, and differentiation.
  • Optimizing recombinant human Oncostatin M (rhOSM) production is crucial for its therapeutic and research applications.

Purpose of the Study:

  • To determine optimal pH for rhOSM expression in Pichia pastoris X-33.
  • To achieve high-level yield of rhOSM through fed-batch fermentation.
  • To purify and characterize the biological activity of the produced rhOSM.

Main Methods:

  • Fed-batch fermentation of rhOSM in an 80 L fermentor using Pichia pastoris X-33.
  • SDS-PAGE and Western blotting for expression analysis.
  • Phenyl Sepharose and SP Sepharose Fast Flow chromatography for purification.
  • Amino-terminal sequencing for N-terminal processing verification.

Main Results:

  • Optimal pH conditions were determined for rhOSM expression.
  • Maximum rhOSM yield reached 280 mg/L with successful secretion.
  • Purified rhOSM (6.94 g, 95% purity) exhibited specific growth inhibition activity (6.26 x 10(4)RU/microg).

Conclusions:

  • Pichia pastoris is an effective host for high-level rhOSM production.
  • The optimized fermentation and purification process yields biologically active rhOSM.
  • This work provides a scalable method for producing rhOSM for further research and potential therapeutic use.

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Scale-Up Processes01:14

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
105
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
96